Cagrilintide is typically considered for: Adults with BMI 30 , or BMI 27 with a metabolic condition Patients who have plateaued on GLP-1 therapy Individuals with strong appetite, cravings, or binge-eating tendencies Those seeking an alternative to or enhancement of weight loss medications Who Should Avoid Cagrilintide
,
119(3): 1121-1126 (2010) Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V
Total monthly cost, including any separate membership, consultation, or shipping charges beyond the headline medication price
As a publisher, our priority is to protect the validity of the scientific record, and, as with all our post-publication investigations, this determined our actions in this case, Chris Graf, research integrity director at Springer Nature, told Spectrum in an email
When used together, they offer a more complete approach to digestive healing